Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors

PDF  |  How to cite

Oncotarget. 2022; 13:1302-1302. https://doi.org/10.18632/oncotarget.28321

Metrics: PDF 261 views  |   ?  

Venkata S.K. Manem1, Olga Sazonova1, Andréanne Gagné1, Michèle Orain1, Babak Khoshkrood-Mansoori1, Nathalie Gaudreault1, Yohan Bossé1,2 and Philippe Joubert1,3

1Quebec Heart and Lung Institute Research Center, Quebec City, QC G1V4G5, Canada
2Department of Molecular Medicine, Laval University, Quebec City, QC G1V4G5, Canada
3Department of Medical Biochemistry, Molecular Biology and Pathology, Laval University, Quebec City, QC G1V4G5, Canada

Published: December 06, 2022

Copyright: © 2022 Manem et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: All human tissues were sourced from the IUCPQ Biobank, which includes only patients that have signed a consent form for research.

Original article: Oncotarget. 2021; 12:209–220. DOI: https://doi.org/10.18632/oncotarget.27874

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28321